Search
for
Sort by
Research 241–270 of 252
- A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia
- Quintaquinone, a Merosesquiterpene from the Yellow Sponge Verongula cf. rigida Esper
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Endophytes in Southeast Asia and Japan: their taxonomic diversity and potential applications
- Demethylation of ITGAV accelerates osteogenic differentiation in a blast-induced heterotopic ossification in vitro cell culture model
- ISID1116 – Novel androgen receptor degrader for androgenetic alopecia (AGA) application
- Quantification of the Vitamin D Receptor−Coregulator Interaction
- Post-transcriptional Regulation of Keratinocyte Progenitor Cell Expansion, Differentiation and Hair Follicle Regression by miR-22
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Frontal Fibrosing Alopecia. An Example of Disrupted Aryl Hydrocarbon Receptor-Mediated Immunological Homeostasis in the Skin?
- Geographic Influence and Metabolomics-Driven Discovery of 5-Alpha Reductase Inhibitors in Tectona grandis L.f. (Teak) Leaves
- Can Plant Extracts Help Prevent Hair Loss or Promote Hair Growth? A Review Comparing Their Therapeutic Efficacies, Phytochemical Components, and Modulatory Targets
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted <sup>99m</sup>Tc-Radioimaging Agents
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Prolongation of off-cycle interval by finasteride is not associated with survival improvement in intermittent androgen deprivation therapy in LNCaP tumor model
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Redefining hormone resistance in prostate cancer
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Alcohol and Prostate Cancer: Time to Draw Conclusions